Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New revision tag added: 'Revision: v3.6.6' replacing the previous 'Revision: v3.6.5'. This appears to be a routine platform update and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small site update. It does not modify the displayed study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-11T21:46:05.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.3 to v3.6.4, signaling a minor technical update rather than any change to study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-21T13:58:26.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a recent update to the page's version history. The change is metadata-level and does not modify the study details or user-facing content on the page.
    Difference
    0.1%
    Check dated 2026-06-30T03:03:06.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page updates include a recruitment status line indicating recruitment is closed, the addition of user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), and a standardized Intervention/Treatment heading; the revision tag is updated to v3.6.0 and the older v3.5.5 tag is removed.
    Difference
    0.5%
    Check dated 2026-06-14T17:45:02.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    An updated revision tag indicates a minor platform update from v3.5.4 to v3.5.5; no study data or page content related to the trial is changed.
    Difference
    0.1%
    Check dated 2026-06-07T14:46:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.